Dr. James  Tin Hang Yip
My Social Links

Dr. James Tin Hang Yip

Business Director
McCann Worldgroup, China


Highest Degree
Ph.D. in Speech and Hearing Sciences from The University of Hong Kong, China

Share this Profile

Biography

James graduated with a BA Honors in Psychology from The University of Western Ontario, CANADA, a masters degree in Neuropsychology and a Ph.D. degree from The University of Hong Kong – specializing in cognitive neurology across a wide spectrum of clinical conditions such as stroke, Parkinson’s disease, schizophrenia, and epilepsy. He has also completed all required taught courses under the Master of Medical Sciences at The University of Hong Kong. He has received prestigious Vivian Smith Advanced Summer Institute Fellowship in 2004 as well as two consecutive years of scholarship from The Sir Edward Youde Memorial Fellowship in 2004 and 2005. He is currently the honorary editor for Advances in Parkinson’s diseases.
After publishing and presenting numerous clinical studies in renowned international medical journals and international conferences, James undertook various strategic planning positions at various DDB, Leo Burnett, and Saatchi & Saatchi where he excelled on pharmaceutical advertising for clients such as GSK and Pfizer. He has also assumed regional and global responsibilities for Leo Burnett on pharmaceutical businesses. Furthermore, he has led numerous quantitative and qualitative research studies for local, regional, and global clients as well.
He has worked extensively on integrated marketing solutions for various other clients as well, including P&G, Intel, Pfizer, Bank of China, ZTE, McDonalds, and Samsung – cutting across traditional, shopper, and online advertising solutions. He has also pioneered offline-online path-to-purchase models and research methodologies and findings for various clients.
James’s clinical and planning expertise and passion for health care and research over the last decade has continued to make him a great asset for companies and clients alike. He strives rigorously to develop strategic business solutions for pharmaceutical and health care clients.

Area of Interest:

Biomedical Sciences
100%
Stroke
62%
Parkinson`s Disease
90%
Epilepsy
75%
Schizophrenia
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
0
Abstracts
0

Selected Publications

  1. Yip, J.T. and T.M. Lee, 2006. Selective impairment of sadness and disgust recognition in abstinent ecstasy users. Neuropsychologia, 44: 959-965.
    CrossRef  |  
  2. Cheung, C.C., T.M. Lee, J.T. Yip, K.E. King and L.S. Li, 2006. The differential effects of thalamus and basal ganglia on facial emotion recognition. Brain and Cognition, 61: 262-268.
    CrossRef  |  
  3. Yip, J.T. and T.M. Lee, 2005. Effect of ecstasy use on neuropsychological function: a study in Hong Kong. Psychopharmacol., 179: 620-628.
    CrossRef  |  
  4. Yip, J.T., K.K. Leung, L.S. Li and T.M. Lee, 2004. The role of sub-cortical brain structures in emotion recognition. Brain Injury, 18: 1209-1217.
    CrossRef  |  
  5. Chan, M.W., J.T. Yip and T.M. Lee, 2004. Differential impairment on measures of attention in patients with paranoid and nonparanoid schizophrenia. J. Psychiatric Res., 38: 145-152.
    CrossRef  |  
  6. Yip, J.T., T. Lee, S.L. Ho, K.L. Tsang and L.S. Li, 2003. Emotion recognition in patients with idiopathic Parkinson’s disease. Mov. Disord., 18: 1115-1122.
    CrossRef  |  
  7. Tong, B.S., J.T. Yip, T.M. Lee and L.S. Li, 2002. Frontal fluency and memory functioning among multiple sclerosis patients in Hong Kong. Brain Injury, 16: 987-995.
    CrossRef  |  
  8. Lee, T., J.T. Yip and M.J. Gotman, 2002. Memory deficits after resection from left or right anterior temporal lobe in humans: a meta-analytic review. Epilepsia, 43: 283-291.
    CrossRef  |